EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration 

Niklas Z Jäntti et al.

Dev Cell. 2025 Jul 9:S1534-5807(25)00403-4. doi: 10.1016/j.devcel.2025.06.025. Online ahead of print.

Published on July 16, 2025

 

ABSTRACT

Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles of EPLIN isoforms (α/β) remain largely unknown and could explain these opposing views. We observed distinct EPLIN isoform localization in breast cancer cells; EPLINα is recruited to actin in plasma membrane ruffles and endosomes, while EPLINβ resides on stress fibers. EPLINα localizes to early endosomes in an actin-dependent manner, where it interacts with Rab21, an established regulator of β1-integrin endosomal trafficking. This supports β1-integrin recycling and cell migration. Using proximity biotinylation (BioID), we identified coronin 1C as an EPLIN-proximal protein, which also localizes at Rab21-containing endosomes and controls integrin recycling downstream of EPLINα. EPLINα expression was linked to increased breast cancer cell motility, and a high EPLINα-to-EPLINβ ratio correlated with a mesenchymal phenotype in patient samples. Our work identifies previously unknown EPLIN-isoform-specific functions relevant to breast cancer and beyond.

PMID:40669465 | DOI:10.1016/j.devcel.2025.06.025

 Read More

Back to Publications
Recent Publication
Markus Lindén et al.Protein Sci. 2026 Jun;35(6):e70621. doi: 10.1002/pro.70621.
Recent Publication
Venla Huovinen et al.Dev Psychopathol. 2026 May 8:1-15. doi: 10.1017/S0954579426101527. Online ahead of print.
Recent Publication
Mona M Wang et al.Commun Biol. 2026 May 5. doi: 10.1038/s42003-026-10118-x. Online ahead of print.
Recent Publication
Wu Yang et al.Biomaterials. 2026 Apr 28;334:124255. doi: 10.1016/j.biomaterials.2026.124255. Online ahead of print.
Recent Publication
James T Grist et al.J Neuroinflammation. 2026 May 4. doi: 10.1186/s12974-026-03839-7. Online ahead of print.